EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions Inc. announced today the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent® FemorOPopliteal Self-Expanding StENt System) clinical trial. The first patient was treated at Midwest Cardiovascular Research Foundation located in Davenport, Iowa by the site’s Principal Investigator and President, Dr. Eric J. Dippel. Shortly thereafter, FSS’s National Study Principle Investigator for the OPEN trial, Dr. William Gray, treated his first patient at Columbia-Presbyterian Hospital where he is the Director of Endovascular Intervention.
